A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab

REFERENCES

1. 1.↵
   1. Cameron JS

   . The nephrotic syndrome and its complications. Am J Kidney Dis 1987;10:157–71.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Glassock RJ

   . Secondary minimal change disease. Nephrol Dial Transplant 2003;18:vi52–8.

   OpenUrlPubMed
3. 3.↵
   1. den Broeder AA,
   2. Assmann KJ,
   3. van Riel PL,
   4. Wetzels JF

   . Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis. Neth J Med 2003;61:137–41.

   OpenUrlPubMed
4. 4.↵
   1. Takeuchi T,
   2. Takegawa M,
   3. Ito Y,
   4. Kishi F,
   5. Miyamoto M,
   6. Minakata T

   . [Minimal change nephrotic syndrome developing in a rheumatoid arthritis patient under etanercept treatment]. [Article in Japanese] Nihon Rinsho Meneki Gakkai Kaishi 2008;31:178–82.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Leong J,
   2. Fung-liu B

   . A case report of nephrotic syndrome due to intake of certolizumab pegol in a patient with Crohn’s disease. Am J Gastroenterol 2010;105:234.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Butendieck RR,
   2. Bhattacharya T,
   3. Geiger X

   . Development of nephrotic syndrome in a patient with rheumatoid arthritis treated with certolizumab. J Rheumatol 2016;43:1770–2.

   OpenUrlFREE Full Text
7. 7.↵
   1. Gottlieb AB,
   2. Chamian F,
   3. Masud S,
   4. Cardinale I,
   5. Abello MV,
   6. Lowes MA,
   7. et al.

   TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 2005;175:2721–9.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Dick AD,
   2. Duncan L,
   3. Hale G,
   4. Waldmann H,
   5. Isaacs J

   . Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmun 1998;11:255–64.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Cho BS,
   2. Yoon SR,
   3. Jang JY,
   4. Pyun KH,
   5. Lee CE

   . Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 1999;13:199–204.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Stefanović V,
    2. Golubović E,
    3. Mitić-zlatković M,
    4. Vlahović P,
    5. Jovanović O,
    6. Bogdanović R

    . Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 1998;12:463–6.

    OpenUrlCrossRefPubMed